5 unknown, 3 completed, 1 recruiting. 9 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Unknown 5, Completed 3, Recruiting 1 |
| Phase 2 | 3 | Unknown 2, Completed 1 |
Follow IVF: new trials by email Literature Review of IVF trials Research Report on IVF
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve Myoinositol, Co-Enzyme Q10, Melatonin - IVF | Phase 3 | Unknown | Beni-Suef University | 200 | 2024-06-30 | 2024-05-08 |
| Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI Dydrogesterone Tablets, Cetrorelix - IVF, PCO | Phase 2 / Phase 3 | Completed | Beni-Suef University | 200 | 2024-01-01 | 2026-04-15 |
| Platelet Rich Plasma on Ovarian Reserve Parameters and Intra Cytoplasmic Sperm Injection Outcomes in Patients With Diminished Ovarian Reserve Intra ovarian by platelet rich plasma - IVF | Phase 3 | Unknown | Beni-Suef University | 56 | 2023-10-30 | 2023-09-21 |
| Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes pentoxifylline 400 mg, (control) - Embryo Transfer, IVF | Phase 3 | Recruiting | Beni-Suef University | 100 | 2023-10-01 | 2026-03-30 |
| Effect of Tadalafil, Sildenafil and Pentoxyfylline on Frozen Embryo Transfer Outcomes tadalafil, Sildenafil, pentoxifylline - IVF | Phase 2 / Phase 3 | Unknown | Beni-Suef University | 200 | 2023-07-30 | 2023-08-03 |
| Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes Dydrogesterone, Cetrorelix acetate, Triptorelin - IVF | Phase 3 | Unknown | Beni-Suef University | 387 | 2023-07-15 | 2023-08-02 |
| The Effect of Sildenafil Citrate on Frozen Embryo Transfer Cycles Sildenafil Citrate, estradiol - IVF | Phase 2 / Phase 3 | Unknown | Beni-Suef University | 110 | 2023-06-30 | 2023-07-19 |
| Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone Progesteron TID - IVF, Embryo Loss | Phase 3 | Completed | University Hospital, Ghent | 87 | 2021-04-02 | 2026-03-23 |
| Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response Progesterone, GnRH Antagonist - IVF, GnRH Antagonist | Phase 3 | Completed | ShangHai Ji Ai Genetics & IVF Institute | 784 | 2020-06-04 | 2023-08-30 |
Embryo Loss (1) · Infertility (1)
Urogenital Diseases (2) · Abortion, Spontaneous (1) · Death (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pregnancy Complications (1)
Dydrogesterone (3) · cetrorelix (3) · Pentoxifylline (2) · Sildenafil Citrate (2) · Estradiol (1) · Folic Acid (1) · Inositol (1) · LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1) · Medroxyprogesterone (1) · Melatonin (1) · Progesterone (1) · Tadalafil (1) · Triptorelin Pamoate (1) · coenzyme Q10 (1) · ganirelix (1)
Beni-Suef University (7) · ShangHai Ji Ai Genetics & IVF Institute (1) · University Hospital, Ghent (1)
Egypt (7) · Belgium (1) · China (1)
Sara A Salem, MD (1)